# Trials recruiting in District of Columbia: 847 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 847 trials recruiting or not yet recruiting with a site in District of Columbia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in District of Columbia: 847 rows for $42.35, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 12 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/district-of-columbia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 847
- Recruiting or not yet: 847
- Read on: November 19, 2026

## Trials

The 25 newest of 847, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 10, 2026 | NCT07929636 | Tracking Outcomes in Patients With Chronic Pain Prescribed Intravenous Lidocaine | International Spine, Pain and Performance Center | Observational | Recruiting | Chronic Pain Syndrome | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929636) |
| November 2, 2026 | NCT07908355 | Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVT Registry™): Registry... | American College of Cardiology | Observational | Recruiting | Aortic Valve Stenosis | 50,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908355) |
| October 28, 2026 | NCT07901738 | Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children | Precigen, Inc | Phase 3 | Not yet recruiting | Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis, Papillomavirus... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901738) |
| October 20, 2026 | NCT07883590 | A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS). | Eli Lilly and Company | Phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis, Cytochrome P-450 Enzyme System | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883590) |
| October 19, 2026 | NCT07881809 | A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881809) |
| October 19, 2026 | NCT07881185 | Artificial Intelligence for Brain MRI Analysis in Epilepsy | Istituto Giannina Gaslini | Observational | Recruiting | Epilepsies | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881185) |
| October 19, 2026 | NCT07880860 | Cleft Lip Scarring After Botox | Children's National Research Institute | Phase 2 | Recruiting | Cleft Lip, Cleft Lip Scar | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880860) |
| October 13, 2026 | NCT07871513 | A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With... | AbbVie | Phase 2 | Recruiting | Upper Facial Lines, Glabellar Lines | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871513) |
| October 13, 2026 | NCT07871448 | Flu COVID Vaccine Views | George Washington University | Observational | Not yet recruiting | Influenza, COVID-19, Vaccination Willingness | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871448) |
| October 8, 2026 | NCT07864714 | UltraTrac Clinical Pilot Study | AcQumen Medical, Inc. | Observational | Not yet recruiting | Hemodynamic Monitoring | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864714) |
| October 1, 2026 | NCT07852247 | SBRT for Ultra-Central NonSmall Cell Lung Cancer | Georgetown University | Phase 1 | Not yet recruiting | Nonsmall Cell Lung Cancer Stage | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852247) |
| October 1, 2026 | NCT07851636 | Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors | Sponsor not shown (see the record) | Not applicable | Recruiting | Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma, PLAG-altered Tumors, Mesenchymal Tumor | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851636) |
| September 30, 2026 | NCT07850609 | A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at... | Merck Sharp & Dohme LLC | Phase 2 | Recruiting | HIV | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850609) |
| September 22, 2026 | NCT07834853 | El Camino HIV Prevention and Care Study | American University | Not applicable | Recruiting | HIV Infections | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834853) |
| September 21, 2026 | NCT07831018 | Impact of AI Care Summaries on Caregiver Comprehension | Children's National Research Institute | Not applicable | Recruiting | Health Literacy, Comprehension, Patient Satisfaction | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831018) |
| September 14, 2026 | NCT07819097 | A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults | Pfizer | Phase 3 | Recruiting | Adult, Healthy Participants | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819097) |
| September 14, 2026 | NCT07818343 | Hinge vs CCK Implants | Medstar Health Research Institute | Not applicable | Recruiting | Revision Arthroplasty, Knee | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818343) |
| September 11, 2026 | NCT07815665 | A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic... | Summit Therapeutics | Phase 2/3 | Recruiting | Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma (UC) | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07815665) |
| September 8, 2026 | NCT07806149 | NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices | National Heart, Lung, and Blood Institute (NHLBI) | Not applicable | Not yet recruiting | Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction, Systolic Anterior Motion | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806149) |
| September 2, 2026 | NCT07799532 | A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury | NervGen Pharma | Phase 3 | Recruiting | Chronic Spinal Cord Injury | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799532) |
| August 31, 2026 | NCT07796061 | Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination... | Children's National Research Institute | Phase 1 | Recruiting | DMG, DIPG | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796061) |
| August 28, 2026 | NCT07789483 | An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy | Alexion Pharmaceuticals, Inc. | Phase 3 | Not yet recruiting | Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 1,180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789483) |
| August 27, 2026 | NCT07789288 | Hard Cervical Collar Use Following Posterior Cervical Fusion | Georgetown University | Not applicable | Recruiting | Spinal Stenosis Cervical, Radiculopathy, Cervical Region, Posterior Cervical Fusion, Spondylosis, Cervical | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789288) |
| August 26, 2026 | NCT07787247 | Feasibility of Remote Monitoring of Patients With Myasthenia Gravis | George Washington University | Observational | Recruiting | Myasthenia Gravis (MG) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787247) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Children's National Medical Center | Washington D.C. | 89 |
| Children's National Hospital | Washington D.C. | 79 |
| MedStar Georgetown University Hospital | Washington D.C. | 73 |
| MedStar Washington Hospital Center | Washington D.C. | 72 |
| Sibley Memorial Hospital | Washington D.C. | 43 |
| Georgetown University | Washington D.C. | 38 |
| Georgetown University Medical Center | Washington D.C. | 36 |
| Medstar Washington Hospital Center | Washington D.C. | 25 |
| George Washington University | Washington D.C. | 22 |
| George Washington University Medical Center | Washington D.C. | 19 |
| Medstar Georgetown University Hospital | Washington D.C. | 13 |
| Children's National Health System | Washington D.C. | 12 |
| Washington Hospital Center | Washington D.C. | 11 |
| Georgetown Lombardi Comprehensive Cancer Center | Washington D.C. | 11 |
| Kaiser Permanente-Capitol Hill Medical Center | Washington D.C. | 11 |
| Georgetown University Hospital | Washington D.C. | 8 |
| Childrens National Medical Center | Washington D.C. | 8 |
| Childrens National Hospital | Washington D.C. | 6 |
| Washington DC VA Medical Center, Washington, DC | Washington D.C. | 6 |
| Emerson Clinical Research Institute | Washington D.C. | 6 |
| The George Washington University | Washington D.C. | 5 |
| MedStar Health Research Institute | Washington D.C. | 5 |
| George Washington University Hospital | Washington D.C. | 5 |
| MedStar National Rehabilitation Hospital | Washington D.C. | 5 |
| Lombardi Comprehensive Cancer Center, Georgetown University | Washington D.C. | 4 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 6 |
| Phase 1 | 55 |
| Phase 1/2 | 60 |
| Phase 2 | 142 |
| Phase 2/3 | 30 |
| Phase 3 | 229 |
| Phase 4 | 15 |
| Not applicable | 149 |
| Observational | 161 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 47 |
| Neoplasms | 32 |
| Lung Neoplasms | 29 |
| Breast Neoplasms | 27 |
| Neoplasm Metastasis | 27 |
| Prostatic Neoplasms | 19 |
| Colorectal Neoplasms | 18 |
| Urinary Bladder Neoplasms | 17 |
| Recurrence | 15 |
| Heart Failure | 15 |
| Brain Neoplasms | 15 |
| Endometrial Neoplasms | 14 |
| Cardiovascular Diseases | 14 |
| Anemia, Sickle Cell | 14 |
| Obesity | 13 |
| Glioma | 13 |
| Stroke | 13 |
| Pancreatic Neoplasms | 11 |
| Leukemia, Myeloid, Acute | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Glioblastoma | 10 |
| Diffuse Intrinsic Pontine Glioma | 10 |
| Multiple Myeloma | 10 |
| Triple Negative Breast Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 38 |
| Children's National Research Institute | 36 |
| Georgetown University | 33 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 21 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 19 |
| Medstar Health Research Institute | 19 |
| George Washington University | 19 |
| Children's Oncology Group | 19 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 17 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 12 |
| NRG Oncology | 11 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 10 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 10 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| Alliance for Clinical Trials in Oncology | 9 |
| SWOG Cancer Research Network | 8 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 8 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 8 |
| Johns Hopkins University | 8 |
| Nationwide Children's Hospital | 8 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 8 |
| VA Office of Research and Development | 7 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 6 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 6 |
| Washington D.C. Veterans Affairs Medical Center | 6 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in District of Columbia

- [Bankruptcy law firms in District of Columbia, United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/district-of-columbia-united-states)
- [Pediatric clinics in District of Columbia, United States](https://specstream.ai/data/businesses/pediatric-clinics/district-of-columbia-united-states)
- [Employment law firms in District of Columbia, United States](https://specstream.ai/data/businesses/employment-law-firms/district-of-columbia-united-states)
- [Architectural design firms in District of Columbia, United States](https://specstream.ai/data/businesses/architectural-design-firms/district-of-columbia-united-states)
- [Naturopathic clinics in District of Columbia, United States](https://specstream.ai/data/businesses/naturopathic-clinics/district-of-columbia-united-states)
- [Doctors' offices in District of Columbia, United States](https://specstream.ai/data/businesses/doctors-offices/district-of-columbia-united-states)
